WHO pointers involve manufacturers to implement a constant danger management approach for sterility test isolators, like frequent chance assessments and the development of danger-based Handle methods. The danger management procedure begins with an intensive analysis of opportunity failure modes as well as their prospective impacts on sterility assurance. Technical waiting for link from Forum Profiles (6)